会议专题

Comparative Proteomic Analysis of Plasma from Hypertensive Patients after Valsartan Treatment

BACKGROUND: This study was designed to investigate the plasma proteomic profile of untreated essential hypertensive (EH) patients and EH patients treated with angiotensin Ⅱ type 1 receptor antagonist (AT1RA) valsartan, which may lead to better understanding of potential pathogenic mechanisms, early diagnosis,prevention and treatment of hypertensive left ventricle hyperplasia (LVH).

Z.G.Wang X.Y.Peng M.Li B.Zhang L.J.Wang J.L.Liu Y.Liu Y.X.Wei S.J.Wen

Beijing Institute of Heart, Lung,Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

国内会议

2015中国老年医学和老年健康产业大会

苏州

英文

346-346

2015-09-11(万方平台首次上网日期,不代表论文的发表时间)